JUN 21, 2022 11:00 AM PDT

Evaluating Monoclonal Gammopathy of Undetermiend Significance (MGUS) with Free Light Chain Assays in Clinical Practice

Sponsored by: Siemens Healthineers

Event Date & Time
Date:  June 21, 2022
Time: 11:00am (PDT),  2:00pm (EDT), 8:00pm (CEST)
Multiple myeloma is a cancer of the plasma cell. Plasma cells are white blood cells that make antibodies that help to protect us from infections. However, the cells grow too much in myeloma, crowding out normal cells in the bone marrow that make red blood cells, platelets, and other white blood cells. The purpose of today’s presentation will be to discuss the pathophysiology of multiple myeloma with an emphasis on monoclonal gammopathy of undetermined significance (MGUS). Specifically, the presentation is designed for laboratorians/clinicians who are interested in learning more about the clinical and laboratory investigation of multiple myeloma and MGUS.
Learning Objectives
  • Define multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS)
  • Describe the clinical criteria used to define multiple myeloma
  • Describe the use of free light chains in the evaluation of MGUS
Webinars will be available for unlimited on-demand viewing after live event.

You May Also Like
Loading Comments...